Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

This study has been completed.
Sponsor:
Information provided by:
Kamada, Ltd.
ClinicalTrials.gov Identifier:
NCT00499837
First received: July 11, 2007
Last updated: December 30, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Estimated Primary Completion Date: No date given